Off Patent
June 2027

Prezista

darunavir

Janssen Products LP

Suspension (oral) · NDA 202895

Last listed protection ends
June 26, 2027

The FDA lists 1 patent for Prezista, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 7,700,645
    Claims the drug substance and the drug product
  2. Patent 7,700,645
    Pediatric extension: six more months